Eleni Pontiki

Dr. Eleni Pontiki

School of Pharmacy, Aristotle University of Thessaloniki, Thessaloníki, Kentrikí Makedonía, Greece
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MMMartha Mantzanidou
Martha Mantzanidou
EPEleni Pontiki
Eleni Pontiki
Dimitra Hadjipavlou-LitinaDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
The five-membered heterocyclic group of pyrazoles/pyrazolines plays important role in drug discovery. Pyrazoles and pyrazolines present a wide range of biological activities. The synthesis of the pyrazolines and pyrazole derivatives was accomplished via the condensation of the appropriate substituted aldehydes and acetophenones, suitable chalcones and hydrazine hydrate in absolute ethanol in the presence of drops of glacial acetic acid. The compounds are obtained in good yields 68–99% and their structure was confirmed using IR, 1H-NMR, 13C-NMR and elemental analysis. The novel derivatives were studied in vitro for their antioxidant, anti-lipid peroxidation (AAPH) activities and inhibitory activity of lipoxygenase. Both classes strongly inhibit lipid peroxidation. Compound 2g was the most potent lipoxygenase inhibitor (IC50 = 80 µM). The inhibition of the carrageenin-induced paw edema (CPE) and nociception was also determined, with compounds 2d and 2e being the most potent. Compound 2e inhibited nociception higher than 2d. Pyrazoline 2d was found to be active in a preliminary test, for the investigation of anti-adjuvant-induced disease (AID) activity. Pyrazoline derivatives were found to be more potent than pyrazoles. Docking studies of the most potent LOX inhibitor 2g highlight hydrophobic interactions with VAL126, PHE143, VAL520 and LYS526 and a halogen bond between the chlorine atom and ARG182.

21 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SPStergiani Chrysovalanti Peitzika
Stergiani Chrysovalanti Peitzika
EPEleni Pontiki
Eleni Pontiki
Alzheimer’s disease (AD), a neurodegenerative brain disorder that affects millions of people worldwide, is characterized by memory loss and cognitive decline. Low levels of acetylcholine and abnormal levels of beta-amyloid, T protein aggregation, inflammation, and oxidative stress, have been associated with AD, and therefore, research has been oriented towards the cholinergic system and primarily on acetylcholinesterase (AChE) inhibitors. In this review, we are focusing on the discovery of AChE inhibitors using computer-based modeling and simulation techniques, covering the recent literature from 2018–2022. More specifically, the review discusses the structures of novel, potent acetylcholinesterase inhibitors and their binding mode to AChE, as well as the physicochemical requirements for the design of potential AChE inhibitors.

7 July 2014 in Molecules
Verified
Journal Article
Open access
PDF file
EPEleni Pontiki
Eleni Pontiki
Dimitra Hadjipavlou-LitinaDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
LKLitinas Konstantinos
Litinas Konstantinos
GGGeorge D. Geromichalos
George D. Geromichalos
Cinnamic acids have been identified as interesting compounds with antioxidant, anti-inflammatory and cytotoxic properties. In the present study, simple cinnamic acids were synthesized by Knoevenagel condensation reactions and evaluated for the above biological activities. Compound 4ii proved to be the most potent LOX inhibitor. Phenyl- substituted acids showed better inhibitory activity against soybean LOX, and it must be noted that compounds 4i and 3i with higher lipophilicity values resulted less active than compounds 2i and 1i. The compounds have shown very good activity in different antioxidant assays. The antitumor properties of these derivatives have been assessed by their 1/IC50 inhibitory values in the proliferation of HT-29, A-549, OAW-42, MDA-MB-231, HeLa and MRC-5 normal cell lines. The compounds presented low antitumor activity considering the IC50 values attained for the cell lines, with the exception of compound 4ii. Molecular docking studies were carried out on cinnamic acid derivative 4ii and were found to be in accordance with our experimental biological results.

1 December 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ABAsunción Burguete
Asunción Burguete
EPEleni Pontiki
Eleni Pontiki
DHDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
RVRaquel Villar
Raquel Villar
AMAntonio Monge
Antonio Monge
AMAntonio Monge
Antonio Monge

9 February 2011 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
ABAsunción Burguete
Asunción Burguete
EPEleni Pontiki
Eleni Pontiki
Dimitra Hadjipavlou-LitinaDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
SASaioa Ancizu
Saioa Ancizu
RVRaquel Villar
Raquel Villar
AMAntonio Monge
Antonio Monge

19 December 2011 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
EPEleni Pontiki
Eleni Pontiki
DHDimitra Hadjipavlou‐Litina
Dimitra Hadjipavlou‐Litina